Search
CalciMedica Inc
CALCAdd to Watchlist
1.115USD
+0.085+8.25%
Market hours （ET）Quotes delayed by 15 min
17.56MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Buy
Current Rating
10.333
Target Price
+946.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
CalciMedica Inc
CALC
4
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is CalciMedica Inc's price target?
Analysts forecast that CalciMedica Inc's price target is USD 15.50, with the highest forecast at USD 20.00 and the lowest forecast at USD 13.00.
How have CalciMedica IncCALC's recent earnings per share performed?
The market expectation was USD 0.31, while CalciMedica IncCALC's earnings per share (EPS) for the previous quarter was USD -0.68. EPS for the next quarter is expected at USD -0.26.
What is the analyst rating for CalciMedica Inc?
Based on the ratings of CalciMedica Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.